• Author: Craig C. Teerlink
Clear all

Remote delivery of cancer genetic testing in Veterans with metastatic prostate cancer: A Million Veteran Program pilot study

Abstract: BACKGROUND: Germline pathogenic variants can inform targeted therapy for metastatic prostate cancer (mPC), and improve cancer early detection and risk reduction for …

Genomic risk model to implement precision prostate cancer screening in clinical care: The ProGRESS study

Abstract: Precision healthcare aims to tailor disease prevention and early detection to individual risk. Prostate cancer screening may benefit from genomics-informed approaches. We …

The impact of race on survival and treatment in Veterans treated for metastatic castration-resistant prostate cancer

Abstract: Background: Black individuals have higher incidence and mortality rates of prostate cancer than White individuals, and existing literature on treatment sequencing …

Risk of systemic manifestations in homozygous carriers of the transthyretinV142I variant: A Million Veteran Program analysis

Abstract:Hereditary transthyretin amyloidosis is caused by pathogenic variants in the TTR gene, resulting in abnormal TTR (transthyretin) that deposits in organs. The c.424G>A …

Drug-gene interactions and clinical outcomes after vascular surgery in the Million Veteran Program

Abstract: IMPORTANCE: Pharmacogenetics can improve medication-related outcomes by optimizing efficacy and minimizing adverse effects. It is unknown whether the presence of …

Discovery of novel ancestry specific genes for androgens and hypogonadism in Million Veteran Program men

Abstract: Given the various roles of testosterone in men’s health, we conducted a multi-ancestral genetic analysis of total testosterone, free testosterone, SHBG, and …